Skip to content

Simultaneously Targeting Obesity and Pain: The STOP Trial

A Randomized Clinical Trial of an Integrated Behavioral Self-management Intervention Simultaneously Targeting Obesity and Pain: The STOP Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02100995
Acronym
STOP
Enrollment
Unknown
Registered
2014-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2016-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Pain, Obesity

Brief summary

The purpose of this study is to determine whether an integrated behavioral treatment approach can help overweight or obese individuals who also have chronic pain reduce their weight and manage their pain symptoms. The goal of this research is to develop better treatments for individuals with chronic pain and overweight or obesity. All participants in this study will receive treatment for weight management and/or pain symptoms. Participants will be assigned at random (like we picked it blindly out of a hat) to receive either: (1) Standard behavioral treatment for weight loss; or (2) Standard behavioral treatment for pain management; or (3) Integrated behavioral treatment for weight loss and pain.

Interventions

BEHAVIORALIntervention Simultaneously Targeting Obesity and Pain
BEHAVIORALWeight Loss/Weight Self-Management
BEHAVIORALChronic Pain Self-Management

Sponsors

University of the Sciences in Philadelphia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults aged ≥ 18 * Body mass index (BMI) ≥ 25 * Chronic, non-cancer pain (pain at a level ≥ 4 on a scale of 0-10 on a majority of the days for 6 months or more prior to study participation)

Exclusion criteria

* Have an unstable medical or psychiatric condition * Meet criteria for current substance abuse or dependence * Meet the criteria for bulimia * Non-fluent in spoken or written English * Currently pregnant, pregnant within the past 6 months, trying to get pregnant in the next 3 months * Demonstrate significant cognitive or sensorimotor impairment precluding treatment engagement * Already participating in a similar structured diet or exercise program or pain self-management program or plans to begin such a program outside the study during the next month * At risk for significant adverse cardiovascular events with moderate activity * Plans to relocate within the upcoming 12 months

Design outcomes

Primary

MeasureTime frameDescription
Change in weight from baseline to 12-monthsBaseline, up to 12 monthsBody weight measured using a calibrated digital scale during assessment visits.
Change in pain intensity from baseline to 12 monthsBaseline, up to 12 monthsPain intensity as measured on a numeric ratings scale (NRS) of 0 (no pain) to 10 (worst pain imaginable).

Secondary

MeasureTime frameDescription
Change in pain disability from baseline to 12 monthsBaseline, up to 12 monthsAs measured by West Haven Yale Multidimensional Pain Inventory (WHYMPI).
Change in quality of life from baseline to 12 monthsBaseline, up to 12 monthsAs measured by the SF-36.

Countries

United States

Contacts

Primary ContactMadelyn Ruggieri
hbrlab@usciences.edu215-596-7185
Backup ContactResearch Assistant(s)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026